{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:32:34Z","timestamp":1772062354123,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1124\/dmd.118.080903","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T14:35:31Z","timestamp":1522420531000},"page":"813-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17\u03b1-Ethynylestradiol"],"prefix":"10.1016","volume":"46","author":[{"given":"Hsia-lien","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Hollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.080903_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0015-0282(16)42613-0","article-title":"Evidence of higher ethynylestradiol blood levels in human hypertensive oral contraceptive users","volume":"28","author":"Ahluwalia","year":"1977","journal-title":"Fertil Steril"},{"key":"10.1124\/dmd.118.080903_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bms.1200220602","article-title":"Mass spectrometry in the analysis of glutathione conjugates","volume":"22","author":"Baillie","year":"1993","journal-title":"Biol Mass Spectrom"},{"key":"10.1124\/dmd.118.080903_bib3","first-page":"189","article-title":"Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man","volume":"85","author":"Bolt","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1124\/dmd.118.080903_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx00031a006","article-title":"Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene","volume":"6","author":"Chan","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.118.080903_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1124\/dmd.109.026997","article-title":"Further assessment of 17\u03b1-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro","volume":"37","author":"Chang","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/iub.241","article-title":"Cytochrome P450 enzymes and the heart","volume":"61","author":"Chaudhary","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1124\/dmd.118.080903_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/jpet.109.152017","article-title":"Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo","volume":"329","author":"Chen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1124\/dmd.109.027011","article-title":"Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function","volume":"37","author":"Dutheil","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.HYP.0000208597.87957.89","article-title":"Endothelium-derived epoxyeicosatrienoic acids and vascular function","volume":"47","author":"Fleming","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/dmd.118.080903_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(95)00153-2","article-title":"Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease","volume":"52","author":"Godsland","year":"1995","journal-title":"Contraception"},{"key":"10.1124\/dmd.118.080903_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clpt.2005.06.009","article-title":"Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2","volume":"78","author":"Granfors","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.080903_bib12","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17 \u03b1-ethynylestradiol in humans","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"key":"10.1124\/dmd.118.080903_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.300.1.298","article-title":"Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes","volume":"300","author":"Hashizume","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","article-title":"Eicosanoid signalling pathways in the heart","volume":"82","author":"Jenkins","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/dmd.118.080903_bib15","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-04-4173","article-title":"Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors","volume":"65","author":"Jiang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.118.080903_bib16","first-page":"14","article-title":"Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells","volume":"28","author":"Jiang","year":"2009","journal-title":"Chin J Cancer"},{"key":"10.1124\/dmd.118.080903_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/tx050256o","article-title":"Identification of 17-\u03b1-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6","volume":"19","author":"Kent","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.118.080903_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.300.2.549","article-title":"Effect of 17-\u03b1-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites","volume":"300","author":"Kent","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib19","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1016\/S0021-9258(18)32606-1","article-title":"The cytochrome P-450 active site. Regiospecificity of prosthetic heme alkylation by olefins and acetylenes","volume":"258","author":"Kunze","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.118.080903_bib20","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1021\/bi9904712","article-title":"Discrete species of activated oxygen yield different cytochrome P450 heme adducts from aldehydes","volume":"38","author":"Kuo","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.118.080903_bib21","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.bmcl.2006.02.004","article-title":"Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2","volume":"16","author":"Lafite","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.118.080903_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mcp.2000.108949","article-title":"No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects","volume":"68","author":"Laine","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.080903_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.111.043505","article-title":"Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity","volume":"40","author":"Lee","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/dmd.109.030270","article-title":"Identification of novel substrates for human cytochrome P450 2J2","volume":"38","author":"Lee","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib26","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1124\/dmd.113.053108","article-title":"The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir","volume":"41","author":"Lin","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.106.117861","article-title":"The inactivation of cytochrome P450 3A5 by 17\u03b1-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein","volume":"321","author":"Lin","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1124\/jpet.301.1.160","article-title":"Mechanism-based inactivation of cytochrome P450 3A4 by 17 \u03b1-ethynylestradiol: evidence for heme destruction and covalent binding to protein","volume":"301","author":"Lin","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1124\/jpet.104.071670","article-title":"The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis","volume":"311","author":"Lin","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.080903_bib30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1124\/dmd.117.075846","article-title":"Heme modification contributes to the mechanism-based inactivation of human cytochrome P450 2J2 by two terminal acetylenic compounds","volume":"45","author":"Lin","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib31","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/dmd.106.010488","article-title":"Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A","volume":"34","author":"Liu","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0022-4731(83)90150-4","article-title":"Drug protein conjugates\u2014III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols","volume":"19","author":"Maggs","year":"1983","journal-title":"J Steroid Biochem"},{"key":"10.1124\/dmd.118.080903_bib33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/dmd.30.11.1240","article-title":"Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole","volume":"30","author":"Matsumoto","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015666","article-title":"Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism","volume":"5","author":"Michaud","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/dmd.118.080903_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinyl estradiol\/norethindrone when administered concurrently to HIV-infected women","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/dmd.118.080903_bib36","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1349-7006.2010.01713.x","article-title":"Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists","volume":"101","author":"Nithipatikom","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1124\/dmd.118.080903_bib37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1124\/dmd.118.080903_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/1117-1936.180807","article-title":"The effect of nifedipine on oral contraceptive-induced hypertension in rats","volume":"13","author":"Olatunji","year":"2006","journal-title":"Niger Postgrad Med J"},{"key":"10.1124\/dmd.118.080903_bib39","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/S0021-9258(19)83624-4","article-title":"Branchpoint for heme alkylation and metabolite formation in the oxidation of arylacetylenes by cytochrome P-450","volume":"260","author":"Ortiz de Montellano","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.118.080903_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.118.080903_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0009-9236(03)00202-9","article-title":"Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation","volume":"74","author":"Palovaara","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.080903_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/dmd.112.048264","article-title":"Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors","volume":"41","author":"Ren","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/138920011795713715","article-title":"The roles of cytochrome P450 in ischemic heart disease","volume":"12","author":"Sato","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.118.080903_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/abbi.2001.2574","article-title":"A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function","volume":"395","author":"Scott","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.118.080903_bib45","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ Res"},{"key":"10.1124\/dmd.118.080903_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/dmd.118.080903_bib47","series-title":"Contemporary Enzyme Kinetics and Mechanisms","first-page":"291","article-title":"Mechanism-based enzyme inactivation","author":"Silverman","year":"1966"},{"key":"10.1124\/dmd.118.080903_bib48","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/FPC.0b013e32830e1e16","article-title":"Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease","volume":"18","author":"Smith","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.118.080903_bib49","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.104.000182","article-title":"The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 \u03b1-ethinylestradiol","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.080903_bib50","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.118.080903_bib51","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1128\/AAC.00843-13","article-title":"CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.118.080903_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602532.2013.806537","article-title":"Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance","volume":"45","author":"Xu","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.118.080903_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0026-895X(24)23134-5","article-title":"Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells","volume":"60","author":"Yang","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.080903_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1124\/mol.51.6.931","article-title":"CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance","volume":"51","author":"Zeldin","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.080903_bib55","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0026-895X(25)09539-2","article-title":"CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance","volume":"50","author":"Zeldin","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.080903_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17\u03b1-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.118.080903_bib57","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1194\/jlr.M017319","article-title":"Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-\u03b1-induced injury","volume":"53","author":"Zhao","year":"2012","journal-title":"J Lipid Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.080903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:36:25Z","timestamp":1739903785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624055636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0090955624055636"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.080903","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17\u03b1-Ethynylestradiol","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.080903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}